[Form 4] CORCEPT THERAPEUTICS INC Insider Trading Activity
Rhea-AI Filing Summary
Director James N. Wilson, through the James N. Wilson and Pamela D. Wilson Trust, made a bona fide gift of 28,000 shares of Corcept Therapeutics common stock on March 13, 2026, with no cash changing hands. The filing shows that, after this gift, the trust held 1,106,532 shares, while the James and Pamela Wilson Family Partners entity held 901,067 shares, and each of two 2025 Grantor Retained Annuity Trusts held 200,000 shares. Wilson has voting power over the trust and family partnership holdings but disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 28,000 shares
Net Sell
4 txns
Insider
WILSON JAMES N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 28,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,106,532 shares (Indirect, James N. Wilson and Pamela D. Wilson Trust);
Common Stock — 901,067 shares (Indirect, James and Pamela Wilson Family Partners);
Common Stock — 200,000 shares (Indirect, James N. Wilson 2025 Grantor Retained Annuity Trust.);
Common Stock — 200,000 shares (Indirect, Pamela D. Wilson 2025 Grantor Retained Annuity Trust.)
Footnotes (1)
- F1. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
AI-generated analysis. How Rhea-AI works. Not financial advice.
